Treatment adherence as a social ability: A case of patients with schizophrenia;L'adhérence thérapeutique vue sous l'angle d'une "habileté sociale": Application à une population de patients atteints de schizophrénie

Journal de Pharmacie de Belgique

Volumn 64, Issue 3, 2009, Pages 91-98

  Baudrant Boga, M ^a   Holtzmann, J ^a   Allenet, Benoît ^a   Debeauchamp, I ^a   Giraud Baro, E ^a  

^a NONE

Author keywords

Individual consultation; Psychosocial rehabilitation; Schizophrenia; Social abilities; Treatment adherence

Indexed keywords

CONSULTATION; HEALTH PROGRAM; HUMAN; MEDICAL RESEARCH; PATIENT COMPLIANCE; PSYCHOSOCIAL REHABILITATION; REVIEW; SCHIZOPHRENIA; SELF CONCEPT; FRANCE; PATIENT EDUCATION; PSYCHOLOGICAL ASPECT; SOCIAL BEHAVIOR;

NEUROLEPTIC AGENT;

ANTIPSYCHOTIC AGENTS; FRANCE; HUMANS; PATIENT COMPLIANCE; PATIENT EDUCATION AS TOPIC; SCHIZOPHRENIA; SOCIAL BEHAVIOR;

EID: 70449381282     PISSN: 00472166     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (63)

1. Llorca PM, Miadi-Fargier H, Lançon C et al. Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation. Encephale. 2005;31(2):235-246 (Pubitemid 40684456)
2. Knapp M, Windmeijer F, Brown J et al. Cost-utility analysis of treatment with olanzapine compared with other antipsychotic treatments in patients with schizophrenia in the pan-European SOHO study. Pharmacoeconomics. 2008;26(4):341-358
3. Mladsi DM, Grogg AL, Irish WD et al. Pharmacy cost evaluation of risperidone, olanzapine, and quetia-pine for the treatment of schizophrenia in acute care inpatient settings. Curr Med Res Opin. 2004; 20(12):1883-1893
4. nd edition.
5. Dubeau M.C, Salomé F, Petitjean F. Le programme de remédiation cognitive IPT destiné aux patients schizophrènes : une expérience en hôpital de jour de secteur. Annales Médico Psychologiques 2007; 165:195-199 (Pubitemid 46412259)
6. ème edition, Ed Masson : 1273-1287.
7. Haynes RB, Taylor DW, Sackett DL. Compliance in health care. John Hopkins Univ Press, Baltimore, 1979.
8. Tourette-Turgis C, Rébillon M. Mettre en place une consultation d'observance aux traitements contre le VIH/Sida, de la théorie à la pratique. 2002, Ed Comment Dire.
9. Tarquinio C, Tarquinio M.P. L'observance thérapeutique: déterminants et modèles théoriques, Pratiques psychologiques 2006, doi: 10.1016/j.prps.2006.09.005.
10. Pampallona S, Bollini P, Tibaldi G, et al. Patient adherence in the treatment of depression. Br J Psychiatry. 2002;2:104-109
11. Weiden PJ, Olfson M. Cost of relapse in schizophrenia. Schizophr Bull.1995;3:419-429
12. Fenton W, Blyler C, Heinssen R. Determinants of medication compliance in schizophrenia: empirical and clinical findings. Schizophr Bull. 1997;23:637-651 (Pubitemid 27485972)
13. Charpentier. A, Goudemand M, Thomas P. L'alliance thérapeutique, un enjeu dans la schizophrénie. L'Encéphale. 2009, 55(1): 80-89.
14. Lieberman JA, Stroup TS, McEvoy JP et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005 22; 353(12):1209-1223. Epub 2005 Sep 19.
15. Ayuso-Gutierrez JL, Del Rio Vega JM. Factor influencing relapse in the long term course of schizophrenia. Schizophr Res. 1997; 28(2-3) :199-206.
16. Lieberman JA, Sheitman B, Chakos M et al. The development of treatment resistance in patients with schizophrenia. J Clin Psychopharmacol. 1998; 18(Suppl 1) :20S-4S
17. Wyatt RJ. Neuroleptics and the natural course of schizophrenia. Schizophr Bull.1991; 17(2) :325-351
18. Olfson M, Mechanic D, Hansell S, et al. Predicting medication noncompliance after hospital discharge among patients with schizophrenia. Psychiatr Serv. 2000;2:216-222 (Pubitemid 30082525)
19. Llorca P.M. Partial compliance in schizophrenia and the impact on patient outcomes. Psychiatry Research. 2008. 161:235-247
20. Sokol MC, McGuigan KA, Verbrugge RR et al. Impact of mecication adherence on hospitalization risk and healthcare costs. Med Care. 2005;43:521-530.
21. Cortet B, Bénichou O. Adhérence, observance, persistance, concordance : prenons-nous en charge correctement nos patients ostéoporotiques ? Revue du Rhumatisme. 2006, 73 : e1-e9.
22. Price P.E. Education, psychology and compliance. Diabetes Metab Res Rev. 2008;24:101-105.
23. World Health Organization. Adherence to long term therapies, time for action. 2003:27-30.
24. M. Bourgeois, T. Haustgen, M. Géraud et al. La conscience du trouble en psychiatrie. Historique : les auteurs classiques. Ann Med Psy. 2000;158 :134-147
25. P. Hardy. Approche clinique de l'information sur les médicaments psychotropes. Perspectives psychiatre. 2000;39,1:8-13.
26. M.C Hardy-Bayle, V Olivier, Y Sarfati et al. Approches contemporaines de la clinique des troubles schizophréniques. Encycl Med Chir, Psychiatrie. 1986, 37282, A20:36.
27. M. Faber, M. Vogel, J. Rostaing et al. Amélioration de l'observance médicamenteuse des patients psychotiques chroniques ambulatoires. J. Pharm. Clin. 1998; 17(1) : 40-43.
28. A. Schmitt, N. Lefebvre, I Chéreau et al. Insight et observance dans la schizophrénie. Ann Med Psy. 2006; 164 : 154-158
29. Kikkert MJ, Schene AH, Koeter MWJ, et al. Medication adherence in schizophrenia: exploring patients', carers' and professionals' views. Schizophr Bull.2006;4:786-794 (Pubitemid 44412866)
30. Charpentier A, Goudemand M, Thomas P. L'alliance thérapeutique, un enjeu dans la schizophrénie, L'Encéphale. 2008, doi:10.1016/j.encep.2007.12.009.
31. Urquhart J, De Klerk E. Le manque d'observance thérapeutique: l'apport de quelques recherches récentes. Journal de pharmacie de Belgique. 1996 ; 51(6) :291-294 (Pubitemid 27037484)
32. Roter DL, Hall JA. Strategies for enhancing patient adherence to medical recommendations. JAMA. 1994;1:80.
33. Harvey PD, Bellack AS. Toward a Terminology for Functional Recovery inSchizophrenia Is Functional Remission a Viable Concept? Schizophr Bull. 2009 Jan 6. (Epub ahead of print).
34. Cnaan R.A, Blankertz L, Messinger KW et al..: Psychosocial Rehabilitation: Toward a Definition, Psychosocial Rehabilitation Journal. 1988 ;11(4) :61-77.
35. Vidon G, Antoniol B, Bonnet C et al. La réhabilitation psychosociale en psychiatrie, 1995, Editions Frison-Roche, Paris.
36. Bachrach L.L.: Psychosocial Rehabilitation and Psychiatry in the Care of Long Term Patients, American Journal of Psychiatry. 1992,149(11):1455-1463.
37. Giraud-Baro E. Réhabilitation psychosociale en France. Annales Médico-psychologiques. 2007 ;165(3) :191-194.
38. Lepoutre R, Kannas S, Giraud-Baro E et al. Soigner, réhabiliter : après le congrès de Réh@b. Pluriels La lettre de la Mission Nationale d'Appui en Santé Mentale. Décembre 2005 - Janvier 2006 ; no54-55 : 1-16.
39. Llorca P.M, Miadi-Fargier H, Lancon C et al. Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation. Encephale. 2005;2:235-246 (Pubitemid 40684456)
40. Hofer A, Kemmler G, Eder U et al. Attitudes toward antipsychotics among outpatient clinic attendees with schizophrenia. J Clin Psychiatry. 2002;1:49-53. (Pubitemid 34113487)
41. Van Putten. Why do schizophrenic patients refuse to take their drugs ? Arch Gen Psychiatry. 1974 ;31 :67-72.
42. Lehmann A, Baudrant-Boga M, Allenet B et al. Optimisation de la dispensation des médicaments hospitaliers aux patients ambulatoires Première partie : conception d'un outil d'information destiné au patient. Journal de pharmacie clinique. 2008; 27 (1) :.35-45. (Pubitemid 351550457)
43. Bordenave-Gabriel C, Giraud-Baro E, De Beauchamp I et al. Peut-on établir un lien entre information, connaissance et observance médicamenteuse chez les patients souffrant de troubles psychotiques ? J Phar Clin .2002, 21(2) : 123-132
44. Goldman CR. Toward a definition of psychoeducation. Hosp Community Psychiatry. 1988; 39:666-668
45. Haute Autorité de Santé (HAS). Recommandations : Education thérapeutique du patient. Structuration d'un programme d'éducation thérapeutique du patient dans le champ des maladies chroniques Juin 2007 www.has-sante.fr
46. Zygmunt A, Olfson M, Boyer CA et al. Interventions to improve medication adherence in schizophrenia. Am J Psychiatry. 2002;10:1653-1664
47. Azrin NH, Teichner G. Evaluation of an instructional program for improving medication compliance for chronically mentally ill outpatients.Behav Res Ther. 1998;36(9):849-861.
48. American Psychiatric Association, Treatment Guidelines for Schizophrenia. 2nd edition, Am. J. Psychiatry. 2004; 161:1-56.
49. Anthony W.A, Liberman R.P. The Practice of Psychiatric Rehabilitation: Historical, Conceptual and Research Base, Schizophr. 1986;12: 542-559
50. Liberman R.P, Corrigan PW. Designing new psychosocial treatments for schizophrenia. Psychiatry. 1993 ; 56(3) :238-249
51. Liberman R.P. Module Education au traitement neuroleptique. Cahier du Participant. adaptation française, Unité de Recherche en Santé Mentale au centre Hospitalier de l'Université Laval (Québec), Réseau Francophone des programmes de réhabilitation psychiatrique. Socrate Réhabilitation Charleroi.
52. Eckman T, Wirshing WC, Marder SR et al. Technique for training schizophrenic patients in illness self-management: a controlled trial. Am J Psychiatry. 1992 ;149(11):1549-1555
53. Kemp R, Hayward P, Applewhaite G et al. Compliance therapy in psychotic patients: randomised controlled trial. BMJ. 1996; 10;312(7027):345-9. (Pubitemid 26050038)
54. Kemp R, Kirov G, Everitt B et al. Randomised controlled trial of compliance therapy. 18-month follow-up. Br J Psychiatry. 1998;172:413-419 (Pubitemid 28204550)
55. Prochaska J.O, DiClemente, C.C. Transtheorical therapy toward a more integrative model of change. Psychotherapy: Theory, Research and Practice. 1982, 19(3):276-287.
56. Diclemente CC, Prochaska JO. Toward a comprehensive, transtheoretical model of change : stages of change and addictive behaviors. In : Miller WR, Heather N, editors. Treating addictive behaviors, 1998: 3-24.
57. W. Miller, C. Butler, S. Rollnick. Motivational interviewing in health care: helping patients change behavior. 2007. Ed Guilford.
58. Corrigan PW, McCracken SG, Holmes EP. Motivational interviews as goal assessment for persons with psychiatric disability. Community Ment Health J. 2001; 37(2):113-122
59. Rusch N, Corrigan PW. Motivational interviewing to improve insight and treatment adherence in schizophrenia. Psychiatr Rehabil J. 2002; 26(1):23-32. (Pubitemid 34884450)
60. Paillot CM, Csillik A.S. Stades d'observance des patients schizophrènes chroniques. Journal de Thérapie Comportementale et Cognitive. 2008 ;18 (1) : 32-35
61. Anthony W.A, Cohen M, Farkas M et al. La Réhabilitation psychiatrique. 2004. Socrate Éditions Promarex, Charleroi.
62. Fiszdon JM, Bell MD. Remediation cognitive et thérapie occupationnelle dans le traitement ambulatoire du patient souffrant de schizophrénie. Santé mentale au Québec. 2004 ;29(2) : 117-142.
63. N. Franck. Remediation cognitive chez les patients souffrant de schizophrénie. Ann Médico Psycho. 2007 ; 165(3) : 187-190